| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 449,246 | 394,471 | 339,665 | 410,675 | | Cost of Revenue | 197,619 | 203,934 | 171,960 | 211,590 | | | Gross Profit | 251,627 | 190,537 | 167,705 | 199,085 | | | Operating Expenses | | Research Development | 116,693 | 117,456 | 120,974 | 144,283 | | Selling General and Administrative | 36,544 | 69,419 | 35,339 | 74,376 | | Non Recurring | 8,291 | (17,925) | 28,346 | 61,266 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 90,099 | 21,587 | (16,954) | (80,840) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 983 | (228) | 7,385 | | Earnings Before Interest And Taxes | 92,000 | 22,570 | (17,182) | (73,455) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 92,000 | 22,570 | (17,182) | (73,455) | | Income Tax Expense | 50,048 | 14,472 | 9,244 | (34,671) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 41,952 | 8,098 | (26,426) | (38,784) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 41,952 | 8,098 | (26,426) | (38,784) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $41,952 | $8,098 | ($26,426) | ($38,784) |
|
0.31% Nasdaq 
0.05%
Income Statement
